Abbott Laboratories Net Income 2006-2019 | ABT
Abbott Laboratories annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Abbott Laboratories net income for the quarter ending March 31, 2019 was $0.672B, a 60.77% increase year-over-year.
- Abbott Laboratories net income for the twelve months ending March 31, 2019 was $2.622B, a 450.84% increase year-over-year.
- Abbott Laboratories annual net income for 2018 was $2.368B, a 396.44% increase from 2017.
- Abbott Laboratories annual net income for 2017 was $0.477B, a 65.93% decline from 2016.
- Abbott Laboratories annual net income for 2016 was $1.4B, a 68.35% decline from 2015.
| Abbott Laboratories Annual Net Income (Millions of US $) |
|
|---|---|
| 2018 | $2,368 |
| 2017 | $477 |
| 2016 | $1,400 |
| 2015 | $4,423 |
| 2014 | $2,284 |
| 2013 | $2,576 |
| 2012 | $5,963 |
| 2011 | $4,728 |
| 2010 | $4,626 |
| 2009 | $5,746 |
| 2008 | $4,881 |
| 2007 | $3,606 |
| 2006 | $1,717 |
| 2005 | $3,372 |
| Abbott Laboratories Quarterly Net Income (Millions of US $) |
|
|---|---|
| Q1 2019 | $672 |
| Q4 2018 | $654 |
| Q3 2018 | $563 |
| Q2 2018 | $733 |
| Q1 2018 | $418 |
| Q4 2017 | $-828 |
| Q3 2017 | $603 |
| Q2 2017 | $283 |
| Q1 2017 | $419 |
| Q4 2016 | $798 |
| Q3 2016 | $-329 |
| Q2 2016 | $615 |
| Q1 2016 | $316 |
| Q4 2015 | $767 |
| Q3 2015 | $580 |
| Q2 2015 | $784 |
| Q1 2015 | $2,292 |
| Q4 2014 | $905 |
| Q3 2014 | $538 |
| Q2 2014 | $466 |
| Q1 2014 | $375 |
| Q4 2013 | $590 |
| Q3 2013 | $966 |
| Q2 2013 | $476 |
| Q1 2013 | $544 |
| Q4 2012 | $1,053 |
| Q3 2012 | $1,943 |
| Q2 2012 | $1,725 |
| Q1 2012 | $1,242 |
| Q4 2011 | $1,619 |
| Q3 2011 | $303 |
| Q2 2011 | $1,943 |
| Q1 2011 | $864 |
| Q4 2010 | $1,441 |
| Q3 2010 | $891 |
| Q2 2010 | $1,292 |
| Q1 2010 | $1,003 |
| Q4 2009 | $1,539 |
| Q3 2009 | $1,480 |
| Q2 2009 | $1,288 |
| Q1 2009 | $1,439 |
| Q4 2008 | $1,536 |
| Q3 2008 | $1,085 |
| Q2 2008 | $1,322 |
| Q1 2008 | $938 |
| Q4 2007 | $1,203 |
| Q3 2007 | $717 |
| Q2 2007 | $989 |
| Q1 2007 | $698 |
| Q4 2006 | $-476 |
| Q3 2006 | $716 |
| Q2 2006 | $612 |
| Q1 2006 | $865 |
| Q4 2005 | $976 |
| Q3 2005 | $681 |
| Q2 2005 | $877 |
| Q1 2005 | $838 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $133.667B | $30.578B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $114.132B | 16.69 |
| Stryker (SYK) | United States | $69.756B | 24.90 |
| Boston Scientific (BSX) | United States | $49.905B | 24.25 |
| Baxter (BAX) | United States | $39.019B | 25.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.114B | 16.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.786B | 0.00 |
| Canopy Growth (CGC) | Canada | $16.315B | 0.00 |
| ResMed (RMD) | United States | $14.544B | 27.58 |
| Aurora Cannabis (ACB) | Canada | $9.179B | 64.71 |
| Bio-Rad Laboratories (BIO) | United States | $8.795B | 50.45 |
| Perrigo (PRGO) | Ireland | $6.734B | 10.92 |
| Hill-Rom Holdings (HRC) | United States | $6.397B | 19.79 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.994B | 0.00 |
| Insulet (PODD) | United States | $4.964B | 1664.20 |
| ICU Medical (ICUI) | United States | $4.636B | 28.71 |
| Haemonetics (HAE) | United States | $4.354B | 38.62 |
| Hutchison China MediTech (HCM) | China | $3.962B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.443B | 0.00 |
| Neogen (NEOG) | United States | $3.004B | 48.85 |
| NuVasive (NUVA) | United States | $2.967B | 25.77 |
| Quidel (QDEL) | United States | $2.487B | 22.25 |
| National Vision Holdings (EYE) | United States | $2.276B | 44.77 |
| Aphria (APHA) | $1.957B | 0.00 | |
| HEXO (HEXO) | $1.474B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.338B | 19.24 |
| VAREX IMAGING (VREX) | United States | $1.234B | 24.16 |
| Cardiovascular Systems (CSII) | United States | $1.212B | 870.25 |
| AtriCure (ATRC) | United States | $1.076B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.957B | 25.86 |
| Omeros (OMER) | United States | $0.929B | 0.00 |
| PetIQ (PETQ) | United States | $0.865B | 24.76 |
| Cerus (CERS) | United States | $0.831B | 0.00 |
| MacroGenics (MGNX) | United States | $0.820B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.781B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.725B | 24.66 |
| TG Therapeutics (TGTX) | United States | $0.717B | 0.00 |
| Evolus (EOLS) | United States | $0.708B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.589B | 25.68 |
| Surmodics (SRDX) | United States | $0.584B | 84.94 |
| LeMaitre Vascular (LMAT) | United States | $0.555B | 26.37 |
| Meridian Bioscience (VIVO) | United States | $0.538B | 16.02 |
| Quanterix (QTRX) | United States | $0.515B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.332B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.329B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.326B | 21.19 |
| BioLife Solutions (BLFS) | United States | $0.302B | 124.61 |
| Vapotherm (VAPO) | United States | $0.287B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.270B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.213B | 2.91 |
| Zynex (ZYXI) | United States | $0.172B | 18.38 |
| Bovie Medical (APYX) | United States | $0.140B | 0.00 |
| Chimerix (CMRX) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 6.85 |
| Chembio Diagnostics (CEMI) | United States | $0.122B | 0.00 |
| Surface Oncology (SURF) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 20.32 |
| Female Health (VERU) | United States | $0.088B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.085B | 0.00 |
| Neurotrope (NTRP) | United States | $0.075B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.069B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.067B | 19.86 |
| GUARDION HEALTH (GHSI) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Senestech (SNES) | United States | $0.036B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.031B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.024B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 13.00 |
